The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Oral renin inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Casas, J. P., Chua, W., Loukogeorgakis, S., Vallance, P., Smeeth, L., Hingorani, A. D., & MacAllister, R. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67814-2 · Cited by 745
Bühler, F. R., Laragh, J. H., Baer, L., Vaughan, E. D., & Brunner, H. R. (1972) · New England Journal of Medicine · doi:10.1056/nejm197212142872401 · Cited by 718
Plasma bradykinin in angio-oedema
Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09137-x · Cited by 706
Gradman, A. H., Schmieder, R. E., Lins, R. L., Nussberger, J., Chiang, Y., & Bedigian, M. P. (2005) · Circulation · doi:10.1161/01.cir.0000156466.02908.ed · Cited by 521
Structure-based design of aliskiren, a novel orally effective renin inhibitor
Wood, J. M., Maibaum, J., Rahuel, J., Grütter, M. G., Cohen, N.-C., Rasetti, V., Rüger, H., Göschke, R., Stutz, S., Fuhrer, W., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01451-7 · Cited by 506
Nussberger, J., Wuerzner, G., Jensen, C., & Brunner, H. R. (2002) · Hypertension · doi:10.1161/hy0102.102293 · Cited by 409
Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, Aliskiren
Stanton, A., Jensen, C., Nussberger, J., & O'Brien, E. (2003) · Hypertension · doi:10.1161/01.hyp.0000101688.17370.87 · Cited by 341
Hollenberg, N. K., Fisher, N. D. L., & Price, D. A. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.387 · Cited by 336
Cited by
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319
The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition
Atlas, S. A. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.s8-b.9 · Cited by 722
Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
McMurray, J. J. V., Pitt, B., Latini, R., Maggioni, A. P., Solomon, S. D., Keefe, D. L., Ford, J., Verma, A., & Lewsey, J. (2008) · Circulation: Heart Failure · doi:10.1161/circheartfailure.107.740704 · Cited by 358
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Ghadanfar, M., Weissbach, N., Xiang, Z., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn721 · Cited by 304
The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis
Graus-Nunes, F., & Souza-Mello, V. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.191 · Cited by 43
Metadata
- Authors
- Staessen, J. A., Li, Y., & Richart, T.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 368
- Issue
- 9545
- Pages
- 1449-1456
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2166819422
- Cited by
- 284
- References
- 33
- FWCI
- 25.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral renin inhibitors. https://app.cochat.ai/papers/10.1016/s0140-6736(06)69442-7
- The paper
- Staessen, J. A., Li, Y., & Richart, T. (2006). Oral renin inhibitors. The Lancet. https://doi.org/10.1016/s0140-6736(06)69442-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
